Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro

European Respiratory Journal

Volumn 31, Issue 1, 2008, Pages 118-125

  Yue, T ^a   Roth Z'Graggen, B ^a   Blumenthal, S ^b   Neff, S B ^a   Reyes, L ^a   Booy, C ^a   Steurer, M ^a   Spahn, D R ^a   Neff, T A ^a   Schmid, E R ^a   Beck Schimmer, B ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ORTHOPEDIC UNIVERSITY HOSPITAL BALGRIST   (Switzerland)

Author keywords

Alveolar epithelial cell biology; Effector cells; Heat shock protein; Inflammatory mediators; Lung inflammation; Nitric oxide

Indexed keywords

CARBON DIOXIDE; CYTOKINE; HEAT SHOCK PROTEIN 32; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE 2; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SEVOFLURANE; UNCLASSIFIED DRUG; ANESTHETIC AGENT; ENDOTOXIN; ETHER DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROTECTION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE SEQUENCE; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ACUTE DISEASE; ANIMAL; CHEMISTRY; CYTOLOGY; DISEASE MODEL; EPITHELIUM CELL; IN VITRO STUDY; INJURY; LUNG; LUNG ALVEOLUS; LUNG DISEASE; METABOLISM; MYCOPLASMA; PATHOLOGY;

ACUTE DISEASE; ANESTHETICS; ANIMALS; CARBON DIOXIDE; DISEASE MODELS, ANIMAL; ENDOTOXINS; EPITHELIAL CELLS; FEMALE; LIPOPOLYSACCHARIDES; LUNG; LUNG DISEASES; METHYL ETHERS; MYCOPLASMA; PULMONARY ALVEOLI; RATS;

EID: 45849125807     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00046307     Document Type: Article

References (32)

1. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999; 27: 304-312.
2. Round table conference. Acute lung injury. Am J Respir Crit Care Med 1998; 158: 675-679.
3. Beck-Schimmer B, Schimmer RC, Warner RL, et al. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 1997; 17: 344-352.
4. Yamasawa H, Ishii Y, Kitamura S. Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation 1999; 23: 263-274.
5. Lundien MC, Mohammed KA, Nasreen N, et al. Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury. J Clin Immunol 2002; 22: 144-152.
6. Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer RC. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 2005; 6: 61-66.
7. Beck-Schimmer B, Madjdpour C, Kneller S, et al. Role of alveolar epithelial ICAM-1 in lipopolysachharide-induced lung inflammation. Eur Respir J 2002; 19: 1142-1150.
8. Sheridan BC, McIntyre RC Jr, Meldrum DR, Fullerton DA. L-Arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin. Am J Physiol 1998; 274: L337-L342.
9. Mulligan MS, Hevel JM, Marletta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Nat Acad Sci USA 1991; 88: 6338-6342.
10. Suter D, Spahn DR, Blumenthal S, et al. The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg 2007; 104: 638-645.
11. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
12. Yellon DM, Opie LH. Postconditioning for protection of the infarcting heart. Lancet 2006; 367: 456-458.
13. Douglas WH, Kaighn ME. Clonal isolation of differentiated rat lung cells. In vitro 1974; 10: 230-237.
14. Obal D, Preckel B, Scharbatke H, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87: 905-911.
15. Madjdpour C, Oertli B, Ziegler U, Bonvini JM, Pasch T, Beck-Schimmer B. Lipopolysaccharide induces functional ICAM-1 expression in rat alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000; 278: L572-L579.
16. Simon RH, DeHart PD, Todd RF 3rd, Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest 1986; 78: 1375-1386.
17. Blumenthal S, Borgeat A, Pasch T, et al. Ropivacaine decreases inflammation in experimental endotoxininduced lung injury. Anesthesiology 2006; 104: 961-969.
18. Raeburn CD, Cleveland JC Jr, Zimmerman MA, Harken AH. Organ preconditioning. Arch Surg 2001; 136: 1263-1266.
19. Mullenheim J, Ebel D, Bauer M, et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology 2003; 99: 624-631.
20. Hawaleshka A, Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 1998; 45: 670-682.
21. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004; 100: 707-721.
22. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
23. Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, Meldrum DR. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006; 202: 797-812.
24. Giraud O, Molliex S, Rolland C, et al. Halogenated anesthetics reduce interleukin-1b-induced cytokine secretion by rat alveolar type II cells in primary culture. Anesthesiology 2003; 98: 74-81.
25. Paugam-Burtz C, Molliex S, Lardeux B, et al. Differential effects of halothane and thiopental on surfactant protein C messenger RNA in vivo and in vitro in rats. Anesthesiology 2000; 93: 805-810.
26. Reutershan J, Chang D, Hayes JK, Ley K. Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. Anesthesiology 2006; 104: 511-517.
27. Mendez MP, Morris SB, Wilcoxen S, Greeson E, Moore B, Paine R 3rd, Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 290: L962-L970.
28. Schmal H, Czermak BJ, Lentsch AB, et al. Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol 1998; 161: 3685-3693.
29. Shanley TP, Zhao B, Macariola DR, Denenberg A, Salzman AL, Ward PA. Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med 2002; 30: 1960-1968.
30. Speyer CL, Neff TA, Warner RL, et al. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am J Pathol 2003; 163: 2319-2328.
31. Hoetzel A, Geiger S, Loop T, et al. Differential effects of volatile anesthetics on hepatic heme oxygenase-1 expression in the rat. Anesthesiology 2002; 97: 1318-1321.
32. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313-1324.